Publications by authors named "Luomengjia Dai"

Claim this Profile
P
Prognostic impacts of RHOA G17V mutation in cell-free DNA assessed by droplet digital polymerase chain reaction in patients with angioimmunoblastic T-cell lymphoma.
Yi Miao, Siqi Qian, Ling Gao, Ziyuan Zhou, Luomengjia Dai

Br J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.
Shuchao Qin, Rui Jiang, Luomengjia Dai, Yi Miao, Yeqin Sha

Ann Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort.
Yi Miao, Yeqin Sha, Yi Xia, Shuchao Qin, Rui Jiang, Luomengjia Dai

Blood Cancer J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Identification of atypical mantle cell lymphoma with rearrangement by next-generation sequencing.
Luomengjia Dai, Han Zhang, Wen Chen, Yi Xia, Shuchao Qin

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis